메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions

[ 메디채널 김갑성 기자 ] Designation underscores potential of chemically induced, off-the-shelf cell therapy to address high unmet need in Parkinson's disease, following compelling Phase I clinical data CHENGDU, China, Jan. 19, 2026 -- iRegene Therapeutics Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, today announced that its lead product, NouvNeu001, has been granted Regenerative Medicine Advanced Therapy (RMAT) designation by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson
- 김갑성 기자
- 2026-01-19 21:00
LANDI Global、イノベーションの20年を祝して次世代決済ポートフォリオ「P-Series」を発表

[ 메디채널 황정호 기자 ] シンガポール, 2026年1月19日 -- 決済およびマーチャントプロフェッショナルソリューションの世界的大手であるLANDI Globalは、創立20周年の節目に、最先端の決済ポートフォリオ「P-Series」を公表しました。 20年の経験を土台に、2年に及ぶ研究開発が実を結ぶ今回のローンチは2年以上にわたる集中的な研究開発の成果であり、グローバルな金融・小売部門で変化し続けるセキュリティおよびパフォーマンスのニーズに応えることを目的に設計が進められました。 LANDIのDNAには、グローバルな産業的スケールとローカルな親密さがひとつとなって深く根付いています。20年にわたるリーダーシップと1億3,000万台を超える端末導入実績を持つLANDIは、その比類ない経験を活かして、真のローカルプレゼンスにしか提供できない市場固有の専門知識を活かし、世界クラスのイノベーションを確実に提供します。 P-Series：完全な次世代決済ポートフォリオ新P-Seriesは、20年にわたり現場で実証されてきたノウハウと最先端技術の架け橋となります。高性能でセキュアなトランザクションのために設計されたこの製品シリーズには、最新のオペレーティングシステムAndroid 14と
- 황정호 기자
- 2026-01-19 21:00
랜디 글로벌, 혁신 20주년 맞아 차세대 P-시리즈 결제 포트폴리오 출시

[ 메디채널 황정호 기자 ] 싱가포르 2026년 1월 19일 -- 결제 및 가맹점 전문 솔루션 분야의 글로벌 선도 기업 랜디 글로벌(LANDI Global)이 창립 20주년을 맞아 자사의 가장 진보된 결제 포트폴리오인 P-시리즈(P-Series)를 공개했다. 20년 경험을 바탕으로 2년에 걸친 R&D로 완성 이번 출시는 글로벌 금융 및 리테일 산업의 변화하는 보안•성능 요구에 대응하기 위해 2년 이상 집중적으로 진행된 연구개발의 결실이다. 랜디의 DNA에는 글로벌 산업 규모의 역량과 현지 밀착형 전문성이 결합돼 있다. 20년간지켜온 업계 최고의 지위와 전 세계 1억 3000만 대 이상의 단말기 보급 실적을 바탕으로, 랜디는 현지에서 구축한 입지만이 제공할 수 있는 시장 맞춤형 전문성과 함께 세계적 수준의 혁신을 구현하고 있다. P-시리즈: 차세대 결제 포트폴리오의 완성 새로운 P-시리즈는 20년에 걸쳐 현장에서 검증된 전문성과 최첨단 기술을 연결한다. 고성능 및 보안 거래를 위해 설계된 본 포트폴리오는 최신 Android 14 운영체제와 PCI v7.x 보안 인증을 갖췄
- 황정호 기자
- 2026-01-19 21:00
China's ETF Connect embraces the largest expansion in history as offshore investors' appetite grows

[ 메디채널 황정호 기자 ] 14 ETFs under ChinaAMC are added, making it the largest fund company by total products included BEIJING, Jan. 19, 2026 -- Offshore investors can now access 98 new onshore ETFs through the Stock Connect program starting today, gaining exposures to a wide range of new targets—from the broad-based CSI A500 index to thematic ones such as satellites and non-ferrous metals. The latest expansion on January 19 will see 54 Shanghai-listed ETFs included under northbound Shanghai Stock Connect and 44 Shenzhen-listed ETFs added via the Shenzhen route, according to Hong Kon
- 황정호 기자
- 2026-01-19 20:39
Harvest Global Investments Announces New CEO and Executive Appointments, Deepening Synergy with Parent Company Harvest Fund to Pioneer New Horizons in Cross-Border Investment

HONG KONG, Jan. 19, 2026 -- Harvest Global Investments Limited ("HGI"), the international subsidiary of Harvest Fund Management, today announced a new round of executive leadership appointments. Mr. Charlie Chen, Managing Director of Harvest Fund Management and former Head of the Strategic Institutional Client Business, has been officially appointed as the Chief Executive Officer (CEO) of HGI. He will be responsible for the overall strategic planning and business development of HGI, reporting to Mr. Larry Lu, Chairman of Harvest Global Investments. Concurrently, Mr. Kevin Shu
- 황정호 기자
- 2026-01-19 20:20
Ageing, smoking, oral bacteria and genetic mutations linked to higher stomach cancer risk

[ 메디채널 김갑성 기자 ] Duke-NUS and NUHS scientists uncover a complex web of genetic, age-related and microbial factors that increase the risk of stomach cancer. Age-related blood cell mutations may trigger early changes in the stomach lining, offering new insights into how cancer risk builds over time and underscoring the importance of healthy ageing. Findings point to new ways to identify individuals at highest risk of developing stomach cancer, opening opportunities for targeted prevention and precise screening. SINGAPORE, Jan. 19, 2026 -- Scientists at Duke-NUS Medical School and
- 김갑성 기자
- 2026-01-19 20:07
SHIMENG Supply Chain Management Launches A-Share IPO, Largest External Shareholder Shoucheng Holdings (0697.HK) Sees Investment Value Enter Realization Phase

HONG KONG, Jan. 19, 2026 -- SHIMENG SUPPLY CHAIN MANAGEMENT CO., LTD. ("SHIMENG"), an investee company of Shoucheng Holdings (0697.HK), has recently initiated its initial public offering (IPO) process on the Main Board of the Shenzhen Stock Exchange. This milestone marks another significant value-realization event within Shoucheng Holdings' industrial investment portfolio, providing a clear and verifiable catalyst that reinforces its long-term investment thesis and highlights tangible progress in the logistics and supply-chain services sector. SHIMENG is a professional integr
- 황정호 기자
- 2026-01-19 19:58
Akeso Announces NMPA Acceptance of Second NDA for Gumokimab (IL-17A Inhibitor) in Active Ankylosing Spondylitis

HONG KONG, Jan. 19, 2026 -- Akeso, Inc. (9926.HK) announced that its supplemental New Drug Application (sNDA) for gumokimab (AK111), a novel humanized anti-IL-17A monoclonal antibody for the treatment of active ankylosing spondylitis (AS), has been accepted for review by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). There are approximately 4 million AS patients in China, and gumokimab represents a potentially promising new therapeutic option for this disease. Active ankylosing spondylitis (AS) is the second indication for which gumokimab h
- 김갑성 기자
- 2026-01-19 19:24
Ph fintech GCash gives Filipinos free access to health, loan insurance through GLoan Protect

MANILA, Philippines, Jan. 19, 2026 -- Fuse Financing Inc. (Fuse), the lending arm of the Philippines' leading fintech player GCash together with GInsure, its digital insurance platform, is now giving free insurance coverage to borrowers of its GLoan feature. Available for a limited time, the newest feature, GLoan Protect, provides borrowers with free loan and health insurance, underwritten by Oona Insurance Corporation, for every GLoan disbursement worth a minimum of PHP 500.00 (USD 8.00). "Oftentimes, Filipinos don't think of insurance until it's too late," sa
- 황정호 기자
- 2026-01-19 19:18
フィリピンのフィンテック企業GCash、GLoan Protectを通じてフィリピン人に医療保険とローン保険を無償で提供

[ 메디채널 황정호 기자 ] マニラ、フィリピン, 2026年1月19日 -- フィリピンの大手フィンテック企業GCashの融資部門であるFuse Financing Inc.（Fuse）は、同社のデジタル保険プラットフォームであるGInsureとともに、GLoan機能を利用している借り手に対して無料の保険を提供します。期間限定で利用可能となる最新機能GLoan Protectでは、500.00フィリピンペソ（8.00米ドル）に相当する金額以上のGLoanからの払い出しすべてが対象となる、Oona Insurance Corporationを引受保険会社とする医療保険とローン保険が借り手に無償で提供されます。「フィリピン人の場合、手遅れになるまで保険のことを考えないということがよくあります」とFuse Financing, Inc.の社長兼最高経営責任者（CEO）のTony Isidroが述べています。「GLoanを受け取るたびにお客様にセーフティネットが提供されるように、無償の保険をご用意しました。これで、お客様に追加負担なくより大きな安心と守られている感覚を持っていただけるのではないかと思います」 GLoanに保障を組み込むことで、GCashはFuseとGInsureを通じて借り手に一段上の安心感と、人生の不
- 황정호 기자
- 2026-01-19 19:18

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-01-20_TUE

2026-01-19_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 20일 01시 40분